The ubiquitin-proteasome system (UPS) controls the stability, localization and/or activity of the proteome. However, the identification and characterization of complex individual ubiquitination cascades and their modulators remains a challenge. Here, we report a broadly applicable, multiplexed, miniaturized on-bead technique for real-time monitoring of various ubiquitination-related enzymatic activities. The assay, termed UPS-confocal fluorescence nanoscanning (UPS-CONA), employs a substrate of interest immobilized on a micro-bead and a fluorescently labelled ubiquitin which, upon enzymatic conjugation to the substrate, is quantitatively detected on the bead periphery by confocal imaging. UPS-CONA is suitable for studying individual enzymatic activities, including various E1, E2 and HECT-type E3 enzymes, and for monitoring multi-step reactions within ubiquitination cascades in a single experimental compartment. We demonstrate the power of the UPS-CONA technique by simultaneously following ubiquitin transfer from Ube1 through Ube2L3 to E6AP. We applied this multi-step setup to investigate the selectivity of five ubiquitination inhibitors reportedly targeting different classes of ubiquitination enzymes. Using UPS-CONA, we have identified a new activity of a small molecule E2 inhibitor, BAY 11-7082, and of a HECT E3 inhibitor, heclin, towards the Ube1 enzyme. As a sensitive, quantitative, flexible and reagent-efficient method with a straightforward protocol, UPS-CONA constitutes a powerful tool for interrogation of ubiquitination-related enzymatic pathways and their chemical modulators, and is readily scalable for large experiments.
INTRODUCTION
Post-translational modification of protein substrates by the small modifier protein ubiquitin regulates the stability, localization, interactions and activity of a substantial fraction of the proteome. Disruption of the ubiquitin-proteasome system (UPS) is associated with many diseases, including cancer, neurological disorders, and immune system dysfunction 1 , and as a consequence is a high priority area for drug discovery. In the canonical ubiquitination cascade, the C-terminal carboxylate of ubiquitin is first activated in an ATP-dependent fashion by an E1 ubiquitin-activating enzyme, followed by thioester transfer to an E2 ubiquitin-conjugating enzyme, before subsequent transfer via an E3 ubiquitin ligase to a substrate lysine residue and attachment through an isopeptide linkage. Repetition of this cascade enables a ubiquitin chain to be assembled on the substrate through conjugation of further ubiquitin moieties to one of the seven lysine residues on ubiquitin itself. Different ubiquitin chain linkages can specify different fates for the substrate. For example, K48-linked chains target substrates to the 26S proteasome for rapid degradation, while K63-linked chains can control the assembly of various protein complexes. Protein monoubiquitination also occurs frequently and can direct protein interactions, for example in intracellular vesicular trafficking. Various ubiquitin modifications can be read by dedicated reader domains and can be reversed through the action of specific deubiquitinating enzymes. The human genome encodes two E1 enzymes, 38 E2 enzymes, over 600 E3 enzymes, over 100 deubiquitinating enzymes, as well as various associated scaffolding subunits. The combinatorial promiscuity of ubiquitin system enzymes, including redundant substrate targeting by different E3s, has made the deconvolution of UPS-mediated control far more difficult than originally envisioned, with implications for UPS drug discovery. In addition, only a limited number of small molecule inhibitors of the UPS are available as mechanistic probes and most of these inhibitors are only poorly characterized for specificity 2 . The dearth of reliable methods to assess molecular mode of action of chemical inhibitors with the necessary level of quantification, time resolution and specificity has hindered UPS drug discovery [3] [4] [5] .
The confocal scanning technology (CONA) was originally developed to enable screening of combinatorial chemical libraries directly on the solid bead-based support, which in effect serves as a nanoscale assay compartment [6] [7] [8] [9] [10] [11] . The confocal sectioning of a monolayer of ~100 µm-sized beads imaged on a fluorescence microscope equipped with a scanning stage enables the high-throughput, highly sensitive detection of binding events between a beadlinked small molecule and a fluorescently labelled target protein in solution 6, 8 . Bead-based screening methods are miniaturized, versatile, highly sensitive, quantitative and fast, and have proven successful in identification of numerous small molecule and peptidomimetic binders and inhibitors against difficult protein targets, such as HuR, Importin beta and LFA-1 [9] [10] [11] . To address the need for a robust technique attuned to the multitude of complex UPS reactions, we developed a fluorescence-based on-bead confocal imaging method, termed UPS-confocal fluorescence nanoscanning (UPS-CONA), for quantitative characterization of dynamic ubiquitination reactions in real-time. We demonstrate suitability of UPS-CONA for studying E1, E2 and HECT E3 activities, both individually and in an integrated enzyme reaction cascade. The modularity and miniaturization of UPS-CONA, in combination with high sensitivity, provides a powerful tool for deciphering multi-step reactions by tracking the kinetics of ubiquitin transfer in real-time. In proof-of-concept experiments, we apply UPS-CONA to investigate the specific activity of selected ubiquitination inhibitors and uncover novel inhibitory activities.
RESULTS AND DISCUSSION

A confocal on-bead ubiquitination assay -the concept
To exploit the advantages of the CONA technique in the ubiquitination field, we developed UPS-CONA as a method for detection and characterization of complex ubiquitin enzymemediated reactions. In its new, redefined form, the assay employs a substrate or enzyme of interest, which is immobilized on a polymer micro-bead, and a fluorescently labelled ubiquitin or ubiquitin-like protein modifier (ULM) in solution ( Fig. 1a ). Upon ubiquitin conjugation to the (a) A substrate protein is immobilized on polymer microbeads and incubated with a suitable mix of conjugating enzymes and with a fluorescently labelled ubiquitin. Upon ubiquitin conjugation to the protein substrate, a fluorescent 'ring' will become detectable in the confocal imaging plane across the microbeads. (b) Images of beads in a 384-well plate were acquired using the confocal scanning microscope Opera TM (Perkin Elmer) in brightfield for bead detection (top images) and in the fluorescence emission channel of the dye on ubiquitin for detection of ubiquitin conjugates (bottom images). A reaction without ATP (-ATP) was used as control for possible non-enzymatic binding. Intensity profiles across beads (blue and magenta lines) were used for quantification of fluorescence emission intensity, which is proportional to the amount of conjugated ubiquitin at the concentrations used. (c) Bead crosssection intensity profiles from (b) were acquired using ImageJ software. (d) Intensity profiles of >100 beads in a test well were analyzed as detailed in Methods to calculate average ring intensities in each well. on-bead substrate or enzyme, the fluorescence emission intensity of conjugates is detected by confocal imaging through the equatorial cross-sectional plane of the beads and observed as a fluorescent ring. The high sensitivity of on-bead assays without the need for cumbersome washing steps is achieved by the reduction of the background fluorescence Figure S1 ). After acquisition of confocal images of beads in a multi-well test plate, the ring intensity of hundreds to thousands of micro-beads forming a monolayer on the bottom of the well is analyzed and quantified ( Fig. 1b, c) . Due to the small size of the beads (typically less than 120 µm in diameter) a large number of technical repetitions is enabled and quantification with high statistical power is achieved (see Methods for details).
The on-bead ubiquitination reaction allows for detection of ubiquitin and ULM conjugates on a variety of enzymes and substrates (Fig. 2 ). The charging of ubiquitin to an E1 enzyme can be assayed by immobilizing the E1 on beads and incubating with ubiquitin in solution, together with Mg 2+ -ATP in reaction buffer. Alternatively, an E2 enzyme can be placed on bead and incubated with both the ubiquitin and an E1 enzyme in solution to detect thioester formation on the E2. Similarly, those E3 enzymes that form a direct thioester conjugate with ubiquitin, such as the HECT-type enzymes 12 , can be tested by immobilizing the E3 and incubating with ubiquitin, E1 and an appropriate E2 in solution. Finally, the performance of an entire cascade can be quantified by immobilization of a substrate of interest on beads in the presence of ubiquitin and the appropriate E1, E2 and E3 enzymes in solution (Supporting Information Figure S . 2). Importantly, the flexibility, modularity and single-bead miniaturization of the UPS-CONA assay make it suitable for a plethora of various ubiquitinrelated reactions of high complexity, which are difficult to investigate by existing methods.
Using the same principle, the assay setup can also be applied to monitor the release of ubiquitin from an immobilized E1 into the E2 in solution, to track ubiquitination cascades in a step-by-step fashion ( UPS-CONA assay can be used to monitor various ubiquitin-related reactions. For example, ubiquitin conjugation to E1, E2 enzymes, HECT E3 ligase (E3*) and substrate proteins can be followed by immobilizing the proteins or enzymes of interest on polymer microbeads and incubating them with appropriate reaction components and with a fluorescently labelled ubiquitin. Increase in bead fluorescence will indicate a successful reaction. Ubiquitin release from an on-bead substrate and transfer to a downstream cascade component can also be detected as a decrease of bead fluorescence.
Monitoring activities of E1, E2 and HECT E3 enzymes
To test the broad applicability of the UPS-CONA, we applied the method to different classes of ubiquitination enzymes, namely E1, E2 and HECT E3 enzymes. First, a His6-tagged version of the Ube1 ubiquitin-activating enzyme (E1) was immobilized on commercial Ni 2+ NTA agarose beads, previously sieved to limit their diameters to between 100 µm and 120 µm. The Ube1 beads were transferred to a 384-well plate to form a monolayer, and were incubated with Cy5-labelled ubiquitin (Cy5-Ub) in ubiquitination buffer as described in Methods. Blank beads were used as control for unspecific Cy5-Ub binding and reaction trials without ATP were used as a control for non-enzymatic Cy5-Ub binding to Ube1. Ubiquitin loading onto Ube1 was monitored by confocal detection of the Cy5 fluorescence emission on bead and quantified as detailed in the Methods section. The fluorescent emission intensity denoting ubiquitin conjugation increased rapidly, within minutes of incubation ( Fig. 3a) .
Similar experiments were performed with an immobilized E2 (Ube2L3, Fig. 3b ), in the presence of Cy5-Ub and an untagged Ube1 enzyme in solution. Finally, an immobilized version of the E6-AP ubiquitin ligase, which is a host cell factor for human papillomavirus E6oncoprotein-induced degradation of p53 13 , was incubated with Cy5-Ub, untagged Ube1 and Ube2L3 in solution (E6AP, Fig. 3c ). In all types of experiments, an increase of the Cy5 fluorescence intensity corresponding to ubiquitin thioester formation and/or conjugation was observed over time. A slight decrease of the signal observed after incubation for 90 minutes or longer was likely due to thioester hydrolysis. Addition of the reducing reagent dithiothreitol (DTT) at the end of each reaction revealed the proportion of conjugates attached through a thioester to the immobilized proteins to be: 60% on Ube1, 95% on Ube2L3 and 80% on E6AP (Fig, 3 a, b, c, respectively). The remaining signal on Ube1 is most likely to correspond to the ubiquitin adenylate bound to the adenylation site 14 , while the remaining signal on E6AP likely corresponded to isopeptide bond-linked ubiquitin moieties due to autoubiquitination on E3 lysine residues 15 . As expected, Ube2L3 was exclusively charged with thioester-bound ubiquitin under these conditions 16 . We successfully tested several other ubiquitination and neddylation reactions using UPS-CONA, including ubiquitination of the tumor suppressor protein p53 (Supporting Information Table 1 ). Based on these results, the bead-based assay appears suitable for monitoring various reactions in the primary ubiquitination cascade, and in addition can be used to quantify the thioester-bound ubiquitin fraction relative to total bound ubiquitin.
Figure 3: Ubiquitination activity of E1, E2 and HECT E3 enzymes detected over time using UPS-CONA.
His6-tagged enzymes Ube1 (a), Ube2L3 (b) or E6AP (c) were immobilized on Ni 2+ NTA agarose microbeads, placed in a 384-well plate and incubated in the reaction buffer at 37°C in the presence of Cy5-labelled ubiquitin (a), Cy5-labelled ubiquitin and untagged Ube1 (b) or Cy5-labelled ubiquitin, untagged Ube1 and Ube2L3 (c). Reactions without ATP (-ATP) were used as controls for non-enzymatic binding of Cy5-Ub to the beads. Reactions were performed in triplicates. At the end of each reaction, DTT was added to remove thioester-bound Cy5-Ub from the on-bead enzymes to quantify non-thioester-bound fraction. Images were acquired on the confocal scanning microscope Opera TM (Perkin Elmer), in brightfield for detection of beads and in Cy5 fluorescence emission for detection of Cy5-Ub conjugates. Data were analyzed as described in the Methods. Average ring intensities in each well over time are represented, corresponding to Cy5-Ub conjugated to the on-bead enzyme.
Multiplexing bead populations in a single well
Miniaturization of the assay, and subsequently a potential screening setup, to the single bead level, allows for modularity, multiplexing and flexibility in assay format. Each of the 200 -400 beads placed into one well of a 384 well plate represents a separate technical repeat of the experiment, which thereby provides enhanced statistical power through multiple replicates per well.
To establish a system for investigation of multiple reactions, typical for enzymatic ubiquitination cascades, it was necessary to separately detect, within a well, bead populations to which different proteins were attached. The detection of mixed bead populations can be achieved through labelling of molecules involved in the reaction with spectrally distinct fluorophores and by then mixing these bead populations in a test well for detection with different fluorescence filters (Fig. 4a, b and Supporting Information Figure S   4 ). However, as this approach involves pre-labelling of proteins of interest with dyes, which could affect their activity, a method based on differentiating the bead populations by size was also established. Two bead populations were used: small beads of 40-70 µm in diameter and large beads of 100-120 µm in diameter ( Fig. 4c ). To confirm that the His6-tag-Ni 2+ NTA attachment was stable enough to prevent transfer between different bead populations in one well over time, small beads pre-incubated with His6-eGFP were mixed with blank large beads and vice versa in the same well (Fig. 4d ). The small and large bead populations were separately detected without significant overlap by precisely setting the bead size parameters (Supporting Information Figure S These results demonstrated that each bead can be considered as a separate reaction unit, thereby allowing monitoring of more than one reaction in a single well. His6-tagged fluorescent proteins (mTurquoise2 (mTurq2, blue), emGFP (green) and E2-Crimson (red)) were pre-immobilized on individual batches of Ni 2+ NTA agarose beads. The beads were then pooled together in one well of a 384-well plate. Images were acquired using the confocal scanning microscope Opera TM (Perkin Elmer) with 445 nm, 488 nm and 561 nm excitation wavelengths, and detected in three emission channels (475/34, 520/35, 660/150 and 690/70 nm, detailed in Supporting Information Figure S4 ). (b) Images of wells with single and mixed bead populations of mTurquoise2, emGFP and E2-Crimson beads were analyzed and average ring intensities were calculated for each channel. (c) Differential detection of bead populations by size. Large beads were sieved through pore size mesh of 100 and 120 µm, imaged on the Opera TM (Perkin Elmer) at a confocal plane height of 30 µm, and identified in the 60-110 pixel radius range. Small beads were sieved through pore size filters of 40 and 70 µm, imaged on the Opera at the confocal plane of 20 µm and detected in the 30-50 pixel radius range. (d) Each bead is a separate reaction unit. His6-tagged emGFP was immobilized on large or small beads and mixed in one well with blank small or blank large beads. Beads were detected as specified in (c) in brightfield and emGFP fluorescence emission channels. No emGFP was detected on the blank beads present in the same well, indicating the absence of protein transfer between the beads.
Tracking a multi-step ubiquitination cascade
A challenge inherent to multi-enzyme reactions such as for the ubiquitination cascade, is the tracking of activities of various enzymes in a single experiment. To demonstrate the suitability of UPS-CONA for monitoring several serial steps in a reaction cascade, we chose to reconstitute the entire reaction for the E6AP, a clinically relevant E3 enzyme implicated in cervical cancer 17 . A His6-tagged Ube1 enzyme was attached to small beads and a His6tagged E6AP to large beads (Fig. 5a ). The two bead populations were then mixed together in one well and incubated with the ubiquitination reaction solution, containing Cy5-Ub and ATP (see Methods). The small Ube1 beads became fluorescent (Fig. 5b ) and the ring intensity reached a plateau within minutes, indicating a successful Cy5-Ub conjugation to Ube1. At this point, we added a non-tagged Ube2L3, the cognate E2 enzyme for E6AP. As the ubiquitin was transferred from the on-bead Ube1 to Ube2L3 in solution, the Cy5-Ub signal on Ube1-bound beads decreased over time (Fig. 5b, c) . Simultaneously, the Cy5-Ub signal increased on the E6AP-bound large bead population, indicating that ubiquitin was conjugated from Ube2L3 in solution to the E6AP on beads (Fig. 5b, c) . This result demonstrated the ability of the UPS-CONA assay to monitor multiple reactions in parallel in a single reaction well.
Target deconvolution of ubiquitination inhibitors
Despite the therapeutic potential of the UPS in cancer and other disease areas, the activity and selectivity of many reported molecules that modulate the UPS are not fully characterized. In particular, assessment of the specificity of a potential inhibitor towards more than one reaction in a cascade requires development of multiple assays. We reasoned that an ideal assay system for addressing target specificity in the UPS should allow enzymatic reactions of the entire cascade to be monitored in parallel. Quantitative and timeresolved monitoring of ubiquitin transfer through the E1-E2-E3 cascade to the final substrate would provide mechanistic insight into the potential effects of an inhibitor at each step. This information would allow triage of hit compounds that lacked the necessary specificity for lead development. To investigate whether UPS-CONA can be used to assess selectivity of ubiquitination inhibitors, we used our multi-step ubiquitination assay to test a selection of known ubiquitination inhibitors: an E1 inhibitor PYR-41 18 , the E2 inhibitors BAY 11-7082 19 and CC0651 20, 21 , and the HECT E3 inhibitors clomipramine 22 and heclin 23 .
BAY 11-7082 inhibits Ube1
The small molecule BAY 11-7082 was first identified as an inflammation inhibitor 24 and has been extensively used as such. More recently, Ube2L3 and other E2 enzymes and ubiquitination enzymes have been identified as direct targets of BAY 11-7082 19 . In our multiactivity UPS-CONA assay with Ube1, Ube2L3 and E6AP, we found that BAY 11-7082 decreased the rate of ubiquitin transfer for all individual reaction steps of the cascade (Fig.   6a ). The combined, overall inhibitory effect of BAY 11-7082 on E6AP was stronger than that of the E1 inhibitor PYR-41 ( Fig. 6a) . To confirm the activity of BAY 11-7082 directly on Ube1, we tested the compound in an on-bead assay with Ube1 alone in the absence of E2 or E3 enzymes (Fig. 6b) . The inhibitory effect of BAY 11-7082 on Ube1 was concentrationdependent, with an IC50 around 3 µM. To confirm that the observed inhibitory activity was not an artefact caused by effects on the fluorescent labels, we tested the compound in a standard SDS-PAGE ubiquitination assay. After optimizing the reaction conditions (see Supporting Methods), we determined that BAY 11-7082 inhibited Ube1 with an IC50 of ~4.6 µM in the gel-based assay (Fig. 6c ). The magnitude of this effect was similar to the inhibition observed for other targets of BAY 11-7082 19 and may in part explain the pan-inhibitory effect of BAY 11-7082 on E2 enzymes. In a similar experimental design, we observed that the E3 inhibitor heclin also affected ubiquitin loading onto Ube1 (Fig. 6b, d) . The IC50 of 20 µM for this inhibitory effect of heclin was somewhat higher than the IC50 values of 6-7 µM reported for inhibition of other HECT E3s 23 but nonetheless suggested that E1 inhibition may also account for some activity of heclin. In contrast, we found that CC0651 and clomipramine had no detectable effect on Ube1 activity (Fig. 6b, d ). Detecting inhibitor effects on Ube1 activity using time-resolved UPS-CONA. Ube1 was immobilized on beads, preincubated with compounds at indicated concentrations for 15 minutes at 25°C and incubated with Cy5-Ub and ATP in ubiquitination buffer to measure inhibition effect. Images were acquired on the Opera TM instrument and analyzed to quantify ubiquitin loading on Ube1. BAY 11-7082 and heclin inhibited the reaction in a concentrationdependent manner. (c) Gel-based assay for BAY 11-7082 inhibition of Ube1. Ube1 was preincubated in the ubiquitination buffer with the test compound at indicated concentrations prior to adding WT-ubiquitin and ATP. After 5 minutes at 30°C, the reactions were stopped by adding SDS loading buffer. Samples were resolved by SDS-PAGE and revealed by Western blot with anti-ubiquitin and anti-Ube1 antibodies. Ube1 activity (Ube1~Ub thioester ratio to total Ube1) was quantified using densitometric analysis (ImageJ). The chart shows corresponding inhibition curve generated in four independent experiments. (d) Comparison of inhibition effects on Ube1 observed using UPS-CONA. On the left, dose-dependent inhibition of ubiquitin loading to immobilized Ube1 was observed for PYR-41, BAY 11-7082 and heclin. On the right, quantification of the non-thioester-bound ubiquitin fraction remaining after treatment with DTT revealed potentially different mechanisms of action of BAY 11-7082 and heclin.
Mechanistic insights into enzyme inhibition
As the UPS-CONA readout combines quantitative and time-resolved detection of ubiquitination, we reasoned that it should be possible to resolve selected aspects of inhibition mechanisms. We therefore analyzed the dose-response effects of the aforementioned inhibitors on ubiquitin loading on Ube1 on beads, followed by reduction with DTT ( Fig. 6d ). In this format, the signal remaining after DTT treatment would correspond to ubiquitin that interacted with Ube1 through a thioester-independent mechanism. Analysis of the inhibition curves revealed that BAY 11-7082 inhibited up to ~50% of ubiquitin loading onto Ube1 (Fig. 6d, left) , which suggested that this compound may act on only one ubiquitin binding site of Ube1. Since ubiquitin cannot occupy the second thioester site on Ube1 without binding first to the adenylation site, we inferred that the thioester site was likely affected. The DTT-resistant signal was dose-dependent, reaching ~80% at highest compound concentration used (Fig. 6d, right) . This result indicated that the proportion of the thioester-bound ubiquitin was reduced by BAY 11-7082, consistent with an effect on the thioester site on Ube1. This mechanism implied a similar mode of action of BAY 11-7082 as described previously for E2 enzymes, by forming a covalent adduct with the reactive cysteine residues 19 . In contrast, the effect of heclin on Ube1 was less pronounced, and similar to PYR-41 in the shape of the inhibition curve (Fig. 6d, left) . However, the proportion of DTT-resistant signal remained unchanged upon increasing heclin concentrations (Fig. 6d,   right ), suggesting that heclin acts through a different mechanism than PYR-41 or BAY 11-7082 23 . As revealed by dose-response curves and DTT treatment, CC0651 and clomipramine did not affect Ube1 activity, which was confirmed in SDS-PAGE ubiquitination assays.
The multi-step monitoring capability of the UPS-CONA assay allowed for identification of a new inhibitory activity of BAY 11-7082 towards Ube1. This information is critical for the ubiquitin community, as this activity will need to be taken into account in assays using this compound so far known as a broad E2 enzyme, but not E1 enzyme inhibitor 19 . To make decisions on further development of any hit compound from a binder screen or an enzymatic screen, the selectivity information is critically important. UPS-CONA resolves biochemical mode of action in one well of a 384-well plate with picomole amounts of reagents, and may be used for selectivity assays, either based on enzyme or ubiquitin mutations, or structureactivity relationships of hit series. Given the small amounts of enzymes with conventional tags needed for UPS-CONA, combined with the sensitivity and time resolved capabilities demonstrated in this work, this method should facilitate the study of reaction mechanisms, mode of action of inhibitors and high-throughput screening campaigns.
Conclusion
We have developed and validated an on-bead confocal detection method called UPS-CONA which is suitable for studying individual enzymatic activities, including various E1, E2 and HECT-type E3 enzymes. We also show that the various ubiquitin-E1-E2-E3 reaction intermediates of a ubiquitination cascade can be followed in a single reaction vessel using an exemplary enzymatic cascade from Ube1 through Ube2L3 to E6AP in a time-resolved manner. A dynamic, confocal detection of fluorescent ubiquitin conjugates ensures a timely, sensitive readout, and a straightforward protocol can be easily automatized for large-scale experiments. Furthermore, our integrated assay is suitable for studying effects of small molecule inhibitors upstream or downstream of the presumptive target against which an inhibitor was originally identified.
UPS-CONA may be parallelized further using different bead sizes to allow simultaneous monitoring of ubiquitination of different substrates in the same reaction or adapted to monitor deubiquitinating enzyme and ubiquitin binding domain activities. Ubiquitin-like modifiers, for example SUMO or NEDD8, may also be monitored in similar assay formats or used for bead-based deconvolution of multiple modification types on a single substrate. Given the robustness of the on-bead fluorescent ring readout to interfering fluorescence from the reactions solutions 7,8 , a lysate-based assay may also be used to study reactions under more physiological conditions, without the need for prior purification of reaction components. The suitability of off-the-shelf confocal imaging instrumentation and commercially available reagents should enable UPS-CONA technology to become a broadly applicable method.
UPS-CONA should therefore be of value for exploring the interactions and activities within combinatorially complex UPS cascades, for identification and characterization of new small molecule probes, and for facilitating UPS drug discovery.
METHODS
Bead preparation
Nickel nitrilotriacetic acid (Ni 2+ NTA) agarose micro-beads were purchased from Qiagen (cat. 
Immobilizing protein on beads
The estimated bead loading capacity as provided by the manufacturer is around 50 mg per 1 mL of the 50 % slurry solution for a protein of around 30 kDa. 1 µL of beads would have a protein loading amount equal to 50 µg of protein. Generally, we used a maximum of 0.5 µM in 20 µL of on-bead protein per well corresponding to 300 ng, which is over 160-fold below saturating amounts. The optimal amount of protein on bead for effective signal detection in our system was determined by using His6-emGFP. Below an amount of 20 pmoles/well we detected a linear relationship between the amount of on-bead emGFP and ring intensity (Supporting Information Figure S1 ). We also verified that the His6-tagged protein was stably attached to the beads for several hours which is probably due to fast on and off rates corresponding to µM dissociation constants given by the tagging system (Supporting Information Figure S3a ). The beads were incubated with the desired quantity of His6-tagged protein (typically 2.5 pmoles per well, or 125 nM) in ice-cold binding buffer on a shaker at 1000 rpm for at least 30 min at 8°C. After incubation, the beads were extensively washed with binding buffer and the volume of bead solution was adjusted to 10 µL per well.
On-bead ubiquitination reaction
Beads with attached proteins were distributed in 10 µL volumes into microplate wells ( emission filters: 690/70 nm (Cy5), 520/35 nm (emGFP). Typically, 77 images from the centre of the well were taken to ensure near-full well coverage and to visualize >100 beads per well, and a well sublayout with 20% image field overlap was applied to allow consequent image stitching. Image data were analyzed using ImageJ and a custom MatLab script.
Data analysis
Full well images are stitched together from multiple individual microscope images using the Grid/Collection Stitching Plugin for ImageJ 25 . The stitched images from each channel, either brightfield or fluorescent, are analyzed for each well in a well plate. The detection in the brightfield channel allows detection of all the beads in a given well, including those with only weak or no fluorescence signal. An edge detection algorithm and Gaussian filtering is applied to the image, followed by a circular Hough transfer to identify circles in the image within a required diameter range (typically between 100 and 120 µm) representing the beads. A canonical list of bead positions and radii in each well is compiled by correlating the beads detected from all the imaging channels. Beads which are incomplete, overlapping or coincide with the image edges are removed from the list. A pre-determined number of profiles (typically 10) is taken across each bead. The peaks representing the 'ring' and the mean of the 20-80th percentiles of the profile intensity between the peaks representing the background bead intensity are identified for each profile. A profile 'intensity' is computed by subtracting the background from the peak intensity. The mean of these backgroundcorrected ring intensity measurements for each bead is computed, giving the bead intensity.
If more than one fluorophore is used in the experiment, the ratio of fluorescence emission intensities of two fluorophores detected on bead is used for an enhanced quantification as it allows for correction against a reference fluorophore, such as a second label on the assayed protein immobilized on beads. Ratiometric analysis is performed by calculating the ratio of the bead intensity of the same bead in multiple fluorescent channels. The mean bead ring intensity of each well in each channel is calculated as the average bead intensity of all the beads in the well. For each well, the mean bead ring intensity and standard deviation are calculated. The optimal amount of protein on bead for effective signal detection was determined by using a His6-tagged Emerald Green Fluorescent Protein (emGFP) standard.
A linear correlation between the amount of on-bead emGFP and ring intensity held for values equal to and below 10 pmoles/well (Supporting Information Figure S1 ). It was also verified that His6-tagged proteins were stably attached to the beads for several hours under typical experimental conditions (Supporting Information Figure S3 ).
